Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 105

1.

Clinical Significance of Plasma Apolipoprotein-AII Isoforms as a Marker of Pancreatic Exocrine Disorder for Patients with Pancreatic Adenocarcinoma Undergoing Chemoradiotherapy, Paying Attention to Pancreatic Morphological Changes.

Hayasaki A, Murata Y, Usui M, Hibi T, Fujii T, Iizawa Y, Kato H, Tanemura A, Azumi Y, Kuriyama N, Kishiwada M, Mizuno S, Sakurai H, Uchida K, Isaji S.

Biomed Res Int. 2019 Apr 4;2019:5738614. doi: 10.1155/2019/5738614. eCollection 2019.

2.

Prognostic Nutritional Index After Chemoradiotherapy Was the Strongest Prognostic Predictor Among Biological and Conditional Factors in Localized Pancreatic Ductal Adenocarcinoma Patients.

Ichikawa K, Mizuno S, Hayasaki A, Kishiwada M, Fujii T, Iizawa Y, Kato H, Tanemura A, Murata Y, Azumi Y, Kuriyama N, Usui M, Sakurai H, Isaji S.

Cancers (Basel). 2019 Apr 10;11(4). pii: E514. doi: 10.3390/cancers11040514.

3.

The clinical impact of portal venous patency ratio on prognosis of patients with pancreatic ductal adenocarcinoma undergoing pancreatectomy with combined resection of portal vein following preoperative chemoradiotherapy.

Jaseanchiun W, Kato H, Hayasaki A, Fujii T, Iizawa Y, Tanemura A, Murata Y, Azumi Y, Kuriyama N, Kishiwada M, Mizuno S, Usui M, Sakurai H, Isaji S.

Pancreatology. 2019 Mar;19(2):307-315. doi: 10.1016/j.pan.2019.01.020. Epub 2019 Jan 25.

PMID:
30738764
4.

Comparative Study Between Gemcitabine-Based and Gemcitabine Plus S1-Based Preoperative Chemoradiotherapy for Localized Pancreatic Ductal Adenocarcinoma, With Special Attention to Initially Locally Advanced Unresectable Tumor.

Takeuchi T, Mizuno S, Murata Y, Hayasaki A, Kishiwada M, Fujii T, Iizawa Y, Kato H, Tanemura A, Kuriyama N, Azumi Y, Usui M, Sakurai H, Isaji S.

Pancreas. 2019 Feb;48(2):281-291. doi: 10.1097/MPA.0000000000001227.

PMID:
30629019
5.

The Critical Role of Biliary Candidiasis in Development of Surgical Site Infections after Pancreatoduodenectomy: Results of Prospective Study Using a Selective Culture Medium for Candida Species.

Kato H, Iizawa Y, Nakamura K, Gyoten K, Hayasaki A, Fujii T, Murata Y, Tanemura A, Kuriyama N, Azumi Y, Kishiwada M, Mizuo S, Usui M, Sakurai H, Isaji S.

Biomed Res Int. 2018 Nov 18;2018:5939724. doi: 10.1155/2018/5939724. eCollection 2018.

6.

Isolated Biliary Fistula After Donor Right Hepatectomy and Its Novel Interventional Treatment: Isolated Liver-Punctured Drainage.

Kato H, Usui M, Nakatsuka A, Hayasaki A, Ito T, Iizawa Y, Murata Y, Tanemura A, Kuriyama N, Azumi Y, Kishiwada M, Mizuno S, Sakurai H, Isaji S.

Transplant Proc. 2018 Nov;50(9):2885-2888. doi: 10.1016/j.transproceed.2018.03.032. Epub 2018 Mar 16.

PMID:
30401417
7.

Recombinant Human Soluble Thrombomodulin Attenuates Hepatic Ischemia and/or Reperfusion Injury by Inhibiting Leukocyte Accumulation in Mice With Normal and Fatty Liver.

Fujii T, Kuriyama N, Hayasaki A, Iizawa Y, Tanemura A, Kato H, Murata Y, Azumi Y, Kishiwada M, Mizuno S, Usui M, Sakurai H, Isaji S.

Transplant Proc. 2018 Nov;50(9):2807-2814. doi: 10.1016/j.transproceed.2018.03.044. Epub 2018 Mar 15.

PMID:
30401402
8.

Biliary Complications During and After Donor Hepatectomy in Living Donor Liver Transplantation Focusing on Characteristics of Biliary Leakage and Treatment for Intraoperative Bile Duct Injury.

Tanemura A, Mizuno S, Hayasaki A, Fujii T, Iizawa Y, Kato H, Murata Y, Kuriyama N, Azumi Y, Kishiwada M, Usui M, Sakurai H, Isaji S.

Transplant Proc. 2018 Nov;50(9):2705-2710. doi: 10.1016/j.transproceed.2018.03.045. Epub 2018 Mar 15.

PMID:
30401381
9.

De Novo Malignancy Following Adult-to-Adult Living Donor Liver Transplantation Focusing on Posttransplantation Lymphoproliferative Disorder.

Mizuno S, Hayasaki A, Ito T, Fujii T, Iizawa Y, Kato H, Murata Y, Tanemura A, Kuriyama N, Azumi Y, Kishiwada M, Usui M, Sakurai H, Isaji S.

Transplant Proc. 2018 Nov;50(9):2699-2704. doi: 10.1016/j.transproceed.2018.03.059. Epub 2018 Mar 15.

PMID:
30401380
10.

Early Enteral Feeding of Daikenchuto Stimulates Early Bowel Movement With Increased Portal Venous Blood Flow After Living Donor Liver Transplantation.

Usui M, Hayasaki A, Fujii T, Iizawa Y, Kato H, Tanemura A, Murata Y, Azumi Y, Kuriyama N, Kishiwada M, Mizuno S, Sakurai H, Isaji S.

Transplant Proc. 2018 Nov;50(9):2690-2694. doi: 10.1016/j.transproceed.2018.03.037. Epub 2018 Mar 16.

PMID:
30401378
11.

Intravenous Administration of Tacrolimus Stabilizes Control of Blood Concentration Regardless of CYP3A5 Polymorphism in Living Donor Liver Transplantation: Comparison of Intravenous Infusion and Oral Administration in Early Postoperative Period.

Kato H, Usui M, Muraki Y, Okuda M, Nakatani K, Hayasaki A, Ito T, Iizawa Y, Murata Y, Tanemura A, Kuriyama N, Azumi Y, Kishiwada M, Mizuno S, Sakurai H, Isaji S.

Transplant Proc. 2018 Nov;50(9):2684-2689. doi: 10.1016/j.transproceed.2018.03.049. Epub 2018 Mar 15.

PMID:
30401377
12.

Feasibility and Outcomes of Direct Dual Portal Vein Anastomosis in Living Donor Liver Transplantation Using the Right Liver Graft With Anatomic Portal Vein Variations.

Kuriyama N, Tanemura A, Hayasaki A, Fujii T, Iizawa Y, Kato H, Murata Y, Azumi Y, Kishiwada M, Mizuno S, Usui M, Sakurai H, Isaji S.

Transplant Proc. 2018 Nov;50(9):2640-2644. doi: 10.1016/j.transproceed.2018.03.053. Epub 2018 Mar 15.

PMID:
30401366
13.

Influence of the intensity of galvanic vestibular stimulation and cutaneous stimulation on the soleus H-reflex in healthy individuals.

Okada Y, Shiozaki T, Nakamura J, Azumi Y, Inazato M, Ono M, Kondo H, Sugitani M, Matsugi A.

Neuroreport. 2018 Sep 5;29(13):1135-1139. doi: 10.1097/WNR.0000000000001086.

PMID:
29965870
14.

Clinical Significance of Histological Effect and Intratumor Stromal Expression of Tenascin-C in Resected Specimens After Chemoradiotherapy for Initially Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma.

Hayasaki A, Murata Y, Usui M, Hibi T, Ito T, Iizawa Y, Kato H, Tanemura A, Azumi Y, Kuriyama N, Kishiwada M, Mizuno S, Sakurai H, Yoshida T, Isaji S.

Pancreas. 2018 Apr;47(4):390-399. doi: 10.1097/MPA.0000000000001022.

PMID:
29517632
15.

Survival Analysis in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Chemoradiotherapy Followed by Surgery According to the International Consensus on the 2017 Definition of Borderline Resectable Cancer.

Hayasaki A, Isaji S, Kishiwada M, Fujii T, Iizawa Y, Kato H, Tanemura A, Murata Y, Azumi Y, Kuriyama N, Mizuno S, Usui M, Sakurai H.

Cancers (Basel). 2018 Mar 5;10(3). pii: E65. doi: 10.3390/cancers10030065.

16.

Long-term outcomes after pancreaticoduodenectomy using pair-watch suturing technique: Different roles of pancreatic duct dilatation and remnant pancreatic volume for the development of pancreatic endocrine and exocrine dysfunction.

Iizawa Y, Kato H, Kishiwada M, Hayasaki A, Tanemura A, Murata Y, Azumi Y, Kuriyama N, Mizuno S, Usui M, Sakurai H, Isaji S.

Pancreatology. 2017 Sep - Oct;17(5):814-821. doi: 10.1016/j.pan.2017.06.008. Epub 2017 Jun 23.

17.

The Prognosis of Severe Acute Pancreatitis Varies According to the Segment Presenting With Low Enhanced Pancreatic Parenchyma on Early Contrast-Enhanced Computed Tomography: A Multicenter Cohort Study.

Kitamura K, Horibe M, Sanui M, Sasaki M, Yamamiya A, Ishii Y, Yoshida H, Sawano H, Goto T, Ikeura T, Hamada T, Oda T, Yasuda H, Ogura Y, Miyazaki D, Hirose K, Chiba N, Ozaki T, Yamashita T, Koinuma T, Oshima T, Yamamoto T, Hirota M, Azumi Y, Nagata K, Saito N, Sato M, Miyamoto K, Iwasaki E, Kanai T, Mayumi T.

Pancreas. 2017 Aug;46(7):867-873. doi: 10.1097/MPA.0000000000000851.

PMID:
28697125
18.

Superiority of stapled side-to-side gastrojejunostomy over conventional hand-sewn end-to-side gastrojejunostomy for reducing the risk of primary delayed gastric emptying after subtotal stomach-preserving pancreaticoduodenectomy.

Murata Y, Tanemura A, Kato H, Kuriyama N, Azumi Y, Kishiwada M, Mizuno S, Usui M, Sakurai H, Isaji S.

Surg Today. 2017 Aug;47(8):1007-1017. doi: 10.1007/s00595-017-1504-z. Epub 2017 Mar 23.

19.

Incidence and Risk Factors of Postoperative Delirium following Pancreatic Surgery: Does the Administration of TJ-54 Reduce the Incidence of Delirium.

Mizuno S, Takeuchi S, Kishiwada M, Mizutani N, Matsuda M, Sekoguchi N, Iizawa Y, Azumi Y, Kuriyama N, Usui M, Sakurai H, Maruyama K, Okuda M, Okada M, Isaji S.

Dig Surg. 2018;35(1):1-10. doi: 10.1159/000456627. Epub 2017 Feb 8.

PMID:
28171868
20.

Pretransplant Serum Hyaluronic Acid Can Be a Biomarker as a Prognostic Predictor in Adult-to-Adult Living Donor Liver Transplantation.

Mizuno S, Das BC, Iizawa Y, Kato H, Murata Y, Tanemura A, Kuriyama N, Azumi Y, Kishiwada M, Usui M, Sakurai H, Isaji S.

Transplant Proc. 2017 Jan - Feb;49(1):102-108. doi: 10.1016/j.transproceed.2016.11.019.

PMID:
28104115
21.

Transhepatic Hilar Approach for Perihilar Cholangiocarcinoma: Significance of Early Judgment of Resectability and Safe Vascular Reconstruction.

Kuriyama N, Isaji S, Tanemura A, Iizawa Y, Kato H, Murata Y, Azumi Y, Kishiwada M, Mizuno S, Usui M, Sakurai H.

J Gastrointest Surg. 2017 Mar;21(3):590-599. doi: 10.1007/s11605-016-3332-7. Epub 2016 Nov 28.

22.

Negative Impact of Biliary Candidiasis on Early and Late Postoperative Complications After Pancreatoduodenectomy Usefulness of the CHROMagar Candida Plate for Identification.

Kato H, Iizawa Y, Kishiwada M, Usui M, Nakamura A, Murata Y, Tanemura A, Kuriyama N, Azumi Y, Mizuno S, Sakurai H, Isaji S.

Pancreas. 2016 Oct;45(9):e45-7. doi: 10.1097/MPA.0000000000000682. No abstract available.

PMID:
27623557
23.

A Novel Predictor of Posttransplant Portal Hypertension in Adult-To-Adult Living Donor Liver Transplantation: Increased Estimated Spleen/Graft Volume Ratio.

Gyoten K, Mizuno S, Kato H, Murata Y, Tanemura A, Azumi Y, Kuriyama N, Kishiwada M, Usui M, Sakurai H, Isaji S.

Transplantation. 2016 Oct;100(10):2138-45. doi: 10.1097/TP.0000000000001370.

24.

Impact of Splenectomy Just Before Partial Orthotopic Liver Transplantation Using Small-for-Size Graft in Rats.

Kuriyama N, Iizawa Y, Kato H, Murata Y, Tanemura A, Azumi Y, Kishiwada M, Mizuno S, Usui M, Sakurai H, Isaji S.

Transplant Proc. 2016 May;48(4):1304-8. doi: 10.1016/j.transproceed.2016.02.041. Erratum in: Transplant Proc. 2017 May;49(4):916.

PMID:
27320610
25.

Influence of Angiotensin-converting Enzyme Genetic Polymorphism on Late Renal Dysfunction After Adult-to-adult Living-donor Liver Transplantation.

Matsui T, Usui M, Fujinaga K, Nakatani K, Iizawa Y, Kato H, Tanemura A, Murata Y, Azumi Y, Kuriyama N, Kishiwada M, Mizuno S, Sakurai H, Isaji S.

Transplant Proc. 2016 May;48(4):1184-9. doi: 10.1016/j.transproceed.2016.02.014.

PMID:
27320583
26.

Discontinuation of Hepatitis B Immunoglobulin by Long-term Hepatitis B Vaccine Inoculation in Preventing Hepatitis B Recurrence After Liver Transplantation.

Usui M, Sugimoto K, Kato H, Murata Y, Tanemura A, Kuriyama N, Azumi Y, Kishiwada M, Mizuno S, Sakurai H, Takei Y, Isaji S.

Transplant Proc. 2016 May;48(4):1179-83. doi: 10.1016/j.transproceed.2015.12.110.

PMID:
27320582
27.

Technical Feasibility and Clinical Outcomes of Interventional Endovascular Treatment for Hepatic Artery Thrombosis After Living-donor Liver Transplantation.

Murata Y, Mizuno S, Kato H, Tanemura A, Kuriyama N, Azumi Y, Kishiwada M, Usui M, Sakurai H, Fujimori M, Yamanaka T, Nakatsuka A, Yamakado K, Isaji S.

Transplant Proc. 2016 May;48(4):1142-8. doi: 10.1016/j.transproceed.2015.12.092.

PMID:
27320575
28.

Long-Term Influence of CYP3A5 Gene Polymorphism on Pharmacokinetics of Tacrolimus and Patient Outcome After Living Donor Liver Transplantation.

Kato H, Usui M, Muraki Y, Tanemura A, Murata Y, Kuriyama N, Azumi Y, Kishiwada M, Mizuno S, Sakurai H, Okuda M, Nakatani K, Isaji S.

Transplant Proc. 2016 May;48(4):1087-94. doi: 10.1016/j.transproceed.2016.02.012.

PMID:
27320564
29.

D-MELD, the Product of Donor Age and Preoperative MELD, Predicts Surgical Outcomes After Living Donor Liver Transplantation, Especially in the Recipients With HCV-positive and Smaller Grafts.

Tanemura A, Mizuno S, Kato H, Murata Y, Kuriyama N, Azumi Y, Kishiwada M, Usui M, Sakurai H, Isaji S.

Transplant Proc. 2016 May;48(4):1025-31. doi: 10.1016/j.transproceed.2015.12.090.

PMID:
27320548
30.

Factor Analysis Influencing Postoperative Hospital Stay and Medical Costs for Patients with Definite, Suspected, or Unmatched Diagnosis of Acute Cholecystitis according to the Tokyo Guidelines 2013.

Hayasaki A, Takahashi K, Fujii T, Kumamoto K, Fujii K, Matsumoto E, Miyahara S, Kusuta T, Azumi Y, Isaji S.

Gastroenterol Res Pract. 2016;2016:7675953. doi: 10.1155/2016/7675953. Epub 2016 Apr 28.

31.

Role of spleen in hepatic ischemia reperfusion injury: Splenic congestion during ischemia accelerates leukocyte infiltration within the liver after reperfusion.

Kato H, Hamada T, Kuriyama N, Ito T, Magawa S, Azumi Y, Kishiwada M, Mizuno S, Usui M, Sakurai H, Isaji S.

Hepatol Res. 2017 Mar;47(3):E132-E141. doi: 10.1111/hepr.12740. Epub 2016 Jun 18.

PMID:
27153152
32.

Comparative Study on the Cytoprotective Effects of Activated Protein C Treatment in Nonsteatotic and Steatotic Livers under Ischemia-Reperfusion Injury.

Matsuda A, Kuriyama N, Kato H, Tanemura A, Murata Y, Azumi Y, Kishiwada M, Mizuno S, Usui M, Sakurai H, Isaji S.

Biomed Res Int. 2015;2015:635041. doi: 10.1155/2015/635041. Epub 2015 Oct 11.

33.

Incidence of esophageal injury after pulmonary vein isolation in patients with a low body mass index and esophageal temperature monitoring at a 39 °C setting.

Kiuchi K, Okajima K, Shimane A, Kanda G, Yokoi K, Teranishi J, Aoki K, Chimura M, Tsubata H, Miyata T, Matsuoka Y, Toba T, Ohishi S, Sawada T, Tsukishiro Y, Onishi T, Kobayashi S, Taniguchi Y, Yamada S, Yasaka Y, Kawai H, Harada T, Ohsawa M, Azumi Y, Nakamoto M.

J Arrhythm. 2015 Feb;31(1):12-7. doi: 10.1016/j.joa.2014.05.002. Epub 2014 Jun 19.

34.

[Open surgical resection for pancreatic cancer].

Azumi Y, Isaji S.

Nihon Rinsho. 2015 Mar;73 Suppl 3:129-33. Japanese. No abstract available.

PMID:
25857000
35.

A new surgical technique of pancreaticoduodenectomy with splenic artery resection for ductal adenocarcinoma of the pancreatic head and/or body invading splenic artery: impact of the balance between surgical radicality and QOL to avoid total pancreatectomy.

Desaki R, Mizuno S, Tanemura A, Kishiwada M, Murata Y, Azumi Y, Kuriyama N, Usui M, Sakurai H, Tabata M, Isaji S.

Biomed Res Int. 2014;2014:219038. doi: 10.1155/2014/219038. Epub 2014 Jun 12.

36.

Paradoxical impact of the remnant pancreatic volume and infectious complications on the development of nonalcoholic fatty liver disease after pancreaticoduodenectomy.

Sato R, Kishiwada M, Kuriyama N, Azumi Y, Mizuno S, Usui M, Sakurai H, Tabata M, Yamada T, Isaji S.

J Hepatobiliary Pancreat Sci. 2014 Aug;21(8):562-72. doi: 10.1002/jhbp.115. Epub 2014 May 14.

PMID:
24824077
37.

Thrombomodulin administration attenuates ischemia-reperfusion injury of the remnant liver after 70% hepatectomy in rats: simulated model of small-for-size graft in living donor liver transplantation.

Tanemura A, Kuriyama N, Azumi Y, Ohsawa I, Kishiwada M, Mizuno S, Usui M, Sakurai H, Tabata M, Isaji S.

Transplant Proc. 2014 May;46(4):1107-11. doi: 10.1016/j.transproceed.2013.11.128.

PMID:
24815140
38.

[Studies on the distribution of doripenem in pancreatic tissues, especially on the importance of the ratio in pancreatic tissue concentration of doripenem/serum concentration of doripenem].

Nobuoka Y, Tanemura A, Azumi Y, Kishiwada M, Osawa I, Mizuno S, Usui M, Sakurai H, Tabata M, Isaji S.

Jpn J Antibiot. 2014 Feb;67(1):15-21. Japanese.

PMID:
24809205
39.

Biliary complications in 108 consecutive recipients with duct-to-duct biliary reconstruction in living-donor liver transplantation.

Mizuno S, Inoue H, Tanemura A, Murata Y, Kuriyama N, Azumi Y, Kishiwada M, Usui M, Sakurai H, Tabata M, Yamada R, Yamamoto N, Sugimoto K, Shiraki K, Takei Y, Isaji S.

Transplant Proc. 2014 Apr;46(3):850-5. doi: 10.1016/j.transproceed.2013.11.035.

PMID:
24767364
40.

Negative prognostic impact of renal replacement therapy in adult living-donor liver transplant recipients: preoperative recipient condition and donor factors.

Iwata H, Mizuno S, Ishikawa E, Tanemura A, Murata Y, Kuriyama N, Azumi Y, Kishiwada M, Usui M, Sakurai H, Tabata M, Yamamoto N, Sugimoto K, Shiraki K, Takei Y, Ito M, Isaji S.

Transplant Proc. 2014 Apr;46(3):716-20. doi: 10.1016/j.transproceed.2013.11.113.

PMID:
24767332
41.

Clinicopathological factors affecting survival and recurrence after initial hepatectomy in non-B non-C hepatocellular carcinoma patients with comparison to hepatitis B or C virus.

Okuda Y, Mizuno S, Shiraishi T, Murata Y, Tanemura A, Azumi Y, Kuriyama N, Kishiwada M, Usui M, Sakurai H, Tabata M, Yamada T, Isaji S.

Biomed Res Int. 2014;2014:975380. doi: 10.1155/2014/975380. Epub 2014 Mar 13.

42.

Anterior approach to the superior mesenteric artery by using nerve plexus hanging maneuver for borderline resectable pancreatic head carcinoma.

Mizuno S, Isaji S, Tanemura A, Kishiwada M, Murata Y, Azumi Y, Kuriyama N, Usui M, Sakurai H, Tabata M.

J Gastrointest Surg. 2014 Jun;18(6):1209-15. doi: 10.1007/s11605-014-2495-3. Epub 2014 Mar 25.

PMID:
24664421
43.

Immunological aspects in late phase of living donor liver transplant patients: usefulness of monitoring peripheral blood CD4+ adenosine triphosphate activity.

Mizuno S, Muraki Y, Nakatani K, Tanemura A, Kuriyama N, Ohsawa I, Azumi Y, Kishiwada M, Usui M, Sakurai H, Tabata M, Yamamoto N, Yamada T, Shiraki K, Takei Y, Nobori T, Okuda M, Isaji S.

Clin Dev Immunol. 2013;2013:982163. doi: 10.1155/2013/982163. Epub 2013 Sep 26.

44.

An approach to the intra-thoracic inferior vena cava through the abdominal cavity preparing for total hepatic vascular exclusion by sagittal diaphragmotomy.

Mizuno S, Yagihara M, Tanemura A, Kuriyama N, Azumi Y, Kishiwada M, Ohsawa I, Usui M, Sakurai H, Tabata M, Miyabe M, Isaji S.

Hepatogastroenterology. 2013 Sep;60(126):1409-12.

PMID:
23933932
45.

Combination assays for evaluation of immune function and CYP3A5 genotype to identify the risk of infectious complications and mortality in living donor liver transplant patients.

Mizuno S, Nakatani K, Muraki Y, Tanemura A, Azumi Y, Kuriyama N, Ohsawa I, Kishiwada M, Usui M, Sakurai H, Tabata M, Okuda M, Nobori T, Isaji S.

Ann Transplant. 2013 Jul 11;18:349-57. doi: 10.12659/AOT.883974.

PMID:
23845965
46.

Proposal for a morphological classification of intraductal papillary neoplasm of the bile duct (IPN-B).

Kato H, Tabata M, Azumi Y, Osawa I, Kishiwada M, Hamada T, Mizuno S, Usui M, Sakurai H, Isaji S.

J Hepatobiliary Pancreat Sci. 2013 Feb;20(2):165-72. doi: 10.1007/s00534-012-0513-y.

PMID:
22426592
47.

Stented pancreaticojejunostomy (with video).

Azumi Y, Isaji S.

J Hepatobiliary Pancreat Sci. 2012 Mar;19(2):116-24. doi: 10.1007/s00534-011-0472-8.

PMID:
22076668
48.

Effect of a prostaglandin I(2) analog on the expression of thrombomodulin in liver and spleen endothelial cells after an extensive hepatectomy.

Usui M, Kato H, Kuriyama N, Azumi Y, Kishiwada M, Mizuno S, Sakurai H, Tabata M, Hayashi T, Suzuki K, Isaji S.

Surg Today. 2011 Feb;41(2):230-6. doi: 10.1007/s00595-009-4263-7. Epub 2011 Jan 26.

PMID:
21264759
49.

A standardized technique for safe pancreaticojejunostomy: Pair-Watch suturing technique.

Azumi Y, Isaji S, Kato H, Nobuoka Y, Kuriyama N, Kishiwada M, Hamada T, Mizuno S, Usui M, Sakurai H, Tabata M.

World J Gastrointest Surg. 2010 Aug 27;2(8):260-4. doi: 10.4240/wjgs.v2.i8.260.

50.

Inhibitory effect of hericenone B from Hericium erinaceus on collagen-induced platelet aggregation.

Mori K, Kikuchi H, Obara Y, Iwashita M, Azumi Y, Kinugasa S, Inatomi S, Oshima Y, Nakahata N.

Phytomedicine. 2010 Dec 1;17(14):1082-5. doi: 10.1016/j.phymed.2010.05.004. Epub 2010 Jul 16.

PMID:
20637576

Supplemental Content

Support Center